Next Article in Journal
Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer
Next Article in Special Issue
Could We Predict the Response of Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma?
Previous Article in Journal
Quantitative Analysis of the MGMT Methylation Status of Glioblastomas in Light of the 2021 WHO Classification
Previous Article in Special Issue
Local and Regional Therapies for Hepatocellular Carcinoma and Future Combinations
 
 
Review

Article Versions Notes

Cancers 2022, 14(13), 3150; https://doi.org/10.3390/cancers14133150
Action Date Notes Link
article pdf uploaded. 27 June 2022 15:20 CEST Version of Record https://www.mdpi.com/2072-6694/14/13/3150/pdf-vor
article xml file uploaded 29 June 2022 09:58 CEST Original file -
article xml uploaded. 29 June 2022 09:58 CEST Update -
article pdf uploaded. 29 June 2022 09:58 CEST Updated version of record https://www.mdpi.com/2072-6694/14/13/3150/pdf-vor
article xml file uploaded 29 June 2022 10:13 CEST Update -
article xml uploaded. 29 June 2022 10:13 CEST Update https://www.mdpi.com/2072-6694/14/13/3150/xml
article pdf uploaded. 29 June 2022 10:13 CEST Updated version of record https://www.mdpi.com/2072-6694/14/13/3150/pdf
article html file updated 29 June 2022 10:16 CEST Original file -
article html file updated 29 June 2022 10:20 CEST Update -
article html file updated 12 August 2022 22:46 CEST Update https://www.mdpi.com/2072-6694/14/13/3150/html
Back to TopTop